Capricor Therapeutics's total assets for Q4 2025 were $355.95M, an increase of 181.52% from the previous quarter. CAPR total liabilities were $50.16M for the fiscal quarter, a 17.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.